A Comprehensive Review of the Role of the Microbiota–Gut–Brain Axis via Neuroinflammation: Advances and Therapeutic Implications for Ischemic Stroke
Biomolecules · 23.06.2025 · 15 (7) · 920
DOI: 10.3390/biom15070920 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 23.06.2025. Verfasst von Hui Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, First Affiliated Hospital of Soochow University, No. 899 Pinghai Road, Suzhou 215006, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Ischemic Stroke, Brain, Neuroinflammatory Diseases. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 225 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xingwei Kejiao science and technology project of Suzhou, Suzhou Basic Research Pilot Project, National Natural Science Foundation of China.
Themen: Schlaganfall
Abstract (Originalsprache)
The human gastrointestinal tract harbors a complex and diverse microbial community. Emerging evidence has revealed bidirectional communication between the gut microbiome and the central nervous system, termed the “microbiota–gut–brain axis”. This axis serves as a critical regulator of glial cell function, positioning it as an essential target for ameliorating the onset and progression of ischemic stroke. In this review, we discuss the developments in the relationship between ischemic stroke and neuroinflammation via MGBA. The gut microbiome plays a critical role in signaling to microglia, astrocytes, and other immune components within this axis. We also summarize the interactions between the gut microbiota and glial cells under both healthy and ischemic stroke conditions. Additionally, we also focus on the role of microbiota-derived metabolites and neurotransmitters in ischemic stroke. Furthermore, we investigate the potential of targeting the intestinal and blood–brain barriers to improve MGBA. Finally, we evaluate the preclinical and clinical evidence for dietary interventions, probiotics, prebiotics, and fecal microbiota transplantation in ischemic stroke. A comprehensive understanding of the MGBA is essential for developing MGBA-based treatment for ischemic stroke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, First Affiliated Hospital of Soochow University, No. 899 Pinghai Road, Suzhou 215006, China.
- Department of Neurology, Dushu Lake Hospital, Suzhou 215006, China.
Förderung
- Xingwei Kejiao science and technology project of Suzhou
- Suzhou Basic Research Pilot Project
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- The Natural Science Foundation of the Jiangsu Higher Education Institutions of China
- Natural Science Foundation of the Jiangsu Higher Education Institutions of China
Zitieren
APA
Guo, H., Tang, X., He, X., Weng, Y., Zhang, Q., Fang, Q., & Zhang, L. (2025). A Comprehensive Review of the Role of the Microbiota–Gut–Brain Axis via Neuroinflammation: Advances and Therapeutic Implications for Ischemic Stroke. Biomolecules, 15(7), 920. https://doi.org/10.3390/biom15070920
Vancouver
Guo H, Tang X, He X, Weng Y, Zhang Q, Fang Q, et al. A Comprehensive Review of the Role of the Microbiota–Gut–Brain Axis via Neuroinflammation: Advances and Therapeutic Implications for Ischemic Stroke. Biomolecules. 2025;15(7):920. doi:10.3390/biom15070920
BibTeX
@article{Guo2025,
author = {Guo, Hui and Tang, Xiang and He, Xinyi and Weng, Yizhen and Zhang, Quanquan and Fang, Qi and Zhang, Lulu},
title = {A Comprehensive Review of the Role of the Microbiota–Gut–Brain Axis via Neuroinflammation: Advances and Therapeutic Implications for Ischemic Stroke},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {7},
pages = {920},
doi = {10.3390/biom15070920}
}
EUVIMED